The Journal of Clinical Pediatric Rheumatology
Online ISSN : 2434-608X
Print ISSN : 2435-1105
A case of 17-year-old girl treated with plasma exchange therapy for lupus nephritis exhibited nephrotic syndrome.
Tomomi SatoSatoko ObayashiYusuke OkudaTomoyuki SakaiToshihiro SawaiKeiji IsshikiTakashi UzuYoshihiro Takeuchi
Author information
JOURNAL FREE ACCESS

2015 Volume 6 Issue 1 Pages 53-56

Details
Abstract

The patient ill this case was a 17-year-old girl with systemic lupus erythematosus (SLE). Ten years after onset, the SLE recurred accompanied by nephrotic syndrome. Lupus nephritis of International Society of Nephrology class lV G(A/C)was diagnosed according to kidney biopsy results. The patient underwent 4 courses of steroid pulse therapy. but her urinary protein levels gradually increased. Her systemic symptoms included marked edema and accumulation of pleuroperitoneal and pericardial fluids. She was admitted to the hospital at age 17 years 6 months. Plasmapheresis was performed to eliminate autoantibodies,which improved the nephrotic symptoms and relieved the edema and accumulated pleuroperitoneal and pericardial fluids. Thereafter,the urinary protein levels gradually decreased. Cyclophosphamide pulse therapy was selected as maintenance immunosuppression therapy. After 8 months, remission of the nephrotic syndrome was achieved、    Lupus nephritis is a serious complication of SLE, which can be a determining factor of patient quality of life and prognosis. In addition to steroids, combined use of mycophenolate mofetil and cyclophosphamide pulse therapy is necessary for the treatment of lupus nephritis class IV. In severe cases of nephrotic syndrome, plasmapheresis is considered as all effective, life-saving treatment in the acute phase.

Content from these authors
© 2015 Pediatric Rheumatology Association of Japan
Previous article Next article
feedback
Top